|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
multiple interactions decreases expression |
ISO |
[cobaltous chloride co-treated with chromic chloride] results in decreased expression of ALPL protein chromic chloride results in decreased expression of ALPL protein |
CTD |
PMID:25966675 |
|
NCBI chr 5:155,234,770...155,289,785
|
|
G |
Aspm |
assembly factor for spindle microtubules |
increases expression |
ISO |
chromic chloride results in increased expression of ASPM mRNA |
CTD |
PMID:12128095 |
|
NCBI chr13:53,625,584...53,674,489
|
|
G |
Bach2 |
BTB domain and CNC homolog 2 |
increases expression |
ISO |
chromic chloride results in increased expression of BACH2 mRNA |
CTD |
PMID:12128095 |
|
NCBI chr 5:46,632,338...46,982,676
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
chromic chloride results in increased expression of BAX protein |
CTD |
PMID:14741615 |
|
NCBI chr 1:105,076,472...105,081,906
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
chromic chloride results in decreased expression of BCL2 protein |
CTD |
PMID:14741615 |
|
NCBI chr13:23,204,464...23,366,900
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
increases expression |
ISO |
chromic chloride results in increased expression of BTG2 mRNA |
CTD |
PMID:12128095 |
|
NCBI chr13:48,083,931...48,087,690
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
chromic chloride results in increased expression of and results in increased activity of CASP3 protein |
CTD |
PMID:14741615 |
|
NCBI chr16:52,395,539...52,413,794
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO |
chromic chloride results in increased expression of and results in increased activity of CASP8 protein |
CTD |
PMID:14741615 |
|
NCBI chr 9:67,747,109...67,806,699
|
|
G |
Cat |
catalase |
increases activity |
EXP |
chromic chloride results in increased activity of CAT protein |
CTD |
PMID:21888059 PMID:23413686 |
|
NCBI chr 3:110,297,340...110,329,526
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression multiple interactions |
ISO |
chromic chloride results in increased expression of CCL2 protein [cobaltous chloride co-treated with chromic chloride] results in increased expression of CCL2 mRNA chromic chloride inhibits the reaction [Glucose results in increased secretion of CCL2 protein] |
CTD |
PMID:17665966 PMID:23629852 PMID:25966675 |
|
NCBI chr10:67,503,077...67,504,875
|
|
G |
Cdc25a |
cell division cycle 25A |
increases expression |
ISO |
chromic chloride results in increased expression of CDC25A mRNA |
CTD |
PMID:12128095 |
|
NCBI chr 8:109,864,356...109,882,734
|
|
G |
Eng |
endoglin |
increases expression |
ISO |
chromic chloride results in increased expression of ENG mRNA |
CTD |
PMID:12128095 |
|
NCBI chr 3:15,934,566...15,972,618
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases activity |
EXP |
chromic chloride results in increased activity of GSR protein |
CTD |
PMID:21888059 PMID:23413686 |
|
NCBI chr16:58,482,209...58,525,256
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
increases expression |
ISO |
chromic chloride results in increased expression of ICAM1 protein |
CTD |
PMID:23629852 |
|
NCBI chr 8:27,829,688...27,841,618
|
|
G |
Igf1 |
insulin-like growth factor 1 |
multiple interactions increases expression |
EXP ISO |
chromic chloride promotes the reaction [INS1 protein results in increased expression of IGF1 mRNA] chromic chloride results in increased expression of IGF1 mRNA |
CTD |
PMID:12153762 PMID:20013160 |
|
NCBI chr 7:24,169,608...24,249,446
|
|
G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
decreases expression |
ISO |
chromic chloride results in decreased expression of IGFBP1 mRNA |
CTD |
PMID:12153762 |
|
NCBI chr14:86,261,277...86,266,344
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression |
ISO |
chromic chloride inhibits the reaction [Glucose results in increased secretion of IL6 protein]; chromic chloride promotes the reaction [Estradiol inhibits the reaction [Glucose results in increased secretion of IL6 protein]] [cobaltous chloride co-treated with chromic chloride] results in increased expression of IL6 mRNA chromic chloride results in increased expression of IL6 mRNA |
CTD |
PMID:15528032 PMID:17665966 PMID:25966675 |
|
NCBI chr 4:5,889,999...5,894,575
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
EXP |
chromic chloride promotes the reaction [INS1 protein results in decreased expression of UBC mRNA]; chromic chloride promotes the reaction [INS1 protein results in increased expression of IGF1 mRNA] |
CTD |
PMID:20013160 |
|
NCBI chr 1:261,186,119...261,186,686
|
|
G |
Ins2 |
insulin 2 |
multiple interactions increases activity |
ISO |
[chromic chloride results in increased activity of INS protein modified form] which results in increased import of Glucose; [chromic chloride results in increased activity of INS protein modified form] which results in increased secretion of Adenosine Triphosphate; Mannose inhibits the reaction [[chromic chloride results in increased activity of INS protein modified form] which results in increased secretion of Adenosine Triphosphate]; Phloretin inhibits the reaction [[chromic chloride results in increased activity of INS protein modified form] which results in increased secretion of Adenosine Triphosphate] |
CTD |
PMID:17965850 |
|
NCBI chr 1:197,843,277...197,992,522
|
|
G |
Insr |
insulin receptor |
increases expression |
EXP |
chromic chloride results in increased expression of INSR mRNA |
CTD |
PMID:19283340 |
|
NCBI chr12:1,193,193...1,330,976
|
|
G |
Lrp5 |
LDL receptor related protein 5 |
multiple interactions |
ISO |
[cobaltous chloride co-treated with chromic chloride] affects the expression of LRP5 mRNA |
CTD |
PMID:25966675 |
|
NCBI chr 1:200,814,247...200,917,581
|
|
G |
Ly6d |
lymphocyte antigen 6 family member D |
decreases expression |
ISO |
chromic chloride results in decreased expression of LY6D mRNA |
CTD |
PMID:12128095 |
|
NCBI chr 7:106,643,225...106,644,733
|
|
G |
Mtf2 |
metal response element binding transcription factor 2 |
increases expression |
ISO |
chromic chloride results in increased expression of MTF2 mRNA |
CTD |
PMID:12128095 |
|
NCBI chr14:1,639,256...1,683,513
|
|
G |
Nfatc1 |
nuclear factor of activated T-cells 1 |
multiple interactions |
ISO |
[cobaltous chloride co-treated with chromic chloride] results in increased expression of NFATC1 mRNA |
CTD |
PMID:25966675 |
|
NCBI chr18:74,046,422...74,156,041
|
|
G |
Pon1 |
paraoxonase 1 |
increases expression |
ISO |
chromic chloride results in increased expression of PON1 mRNA |
CTD |
PMID:12128095 |
|
NCBI chr 4:34,261,312...34,292,327
|
|
G |
Runx2 |
RUNX family transcription factor 2 |
multiple interactions |
ISO |
[cobaltous chloride co-treated with chromic chloride] affects the expression of RUNX2 mRNA |
CTD |
PMID:25966675 |
|
NCBI chr 9:16,167,504...16,492,826
|
|
G |
Sephs2 |
selenophosphate synthetase 2 |
increases expression |
ISO |
chromic chloride results in increased expression of SEPHS2 mRNA |
CTD |
PMID:12128095 |
|
NCBI chr 1:181,893,146...181,895,464
|
|
G |
Serpina1 |
serpin family A member 1 |
decreases activity |
EXP ISO |
chromic chloride results in decreased activity of SERPINA1 protein |
CTD |
PMID:12122574 |
|
NCBI chr 6:122,866,314...122,888,339
|
|
G |
Sgpl1 |
sphingosine-1-phosphate lyase 1 |
increases expression |
ISO |
chromic chloride results in increased expression of SGPL1 mRNA |
CTD |
PMID:12128095 |
|
NCBI chr20:29,047,793...29,094,209
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
affects localization |
ISO |
chromic chloride affects the localization of SLC2A4 protein |
CTD |
PMID:16339278 |
|
NCBI chr10:54,666,015...54,671,581
|
|
G |
Sp7 |
Sp7 transcription factor |
multiple interactions decreases expression |
ISO |
[cobaltous chloride co-treated with chromic chloride] results in decreased expression of SP7 mRNA chromic chloride results in decreased expression of SP7 mRNA |
CTD |
PMID:25966675 |
|
NCBI chr 7:133,484,609...133,494,788
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
chromic chloride inhibits the reaction [[Hydrogen Peroxide co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein] [cobaltous chloride co-treated with chromic chloride] results in increased expression of TNF mRNA |
CTD |
PMID:11726202 PMID:25966675 |
|
NCBI chr20:3,626,685...3,629,303
|
|
G |
Tnfrsf11b |
TNF receptor superfamily member 11B |
multiple interactions decreases expression |
ISO |
[cobaltous chloride co-treated with chromic chloride] results in decreased expression of TNFRSF11B mRNA chromic chloride results in decreased expression of TNFRSF11B mRNA |
CTD |
PMID:25966675 |
|
NCBI chr 7:85,566,520...85,594,526
|
|
G |
Tnfsf11 |
TNF superfamily member 11 |
multiple interactions |
ISO |
[cobaltous chloride co-treated with chromic chloride] results in increased expression of TNFSF11 mRNA |
CTD |
PMID:25966675 |
|
NCBI chr15:53,673,850...53,705,325
|
|
G |
Ubc |
ubiquitin C |
decreases expression multiple interactions |
EXP |
chromic chloride results in decreased expression of UBC mRNA chromic chloride promotes the reaction [INS1 protein results in decreased expression of UBC mRNA] |
CTD |
PMID:20013160 |
|
NCBI chr12:31,239,149...31,243,924
|
|